HCW Biologics (HCWB) Competitors $0.23 -0.01 (-4.82%) Closing price 04:00 PM EasternExtended Trading$0.23 +0.00 (+1.67%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HCWB vs. ATNM, TNYA, FBRX, SKYE, BDRX, ONCY, BLUE, AADI, IMMX, and PEPGShould you be buying HCW Biologics stock or one of its competitors? The main competitors of HCW Biologics include Actinium Pharmaceuticals (ATNM), Tenaya Therapeutics (TNYA), Forte Biosciences (FBRX), Skye Bioscience (SKYE), Biodexa Pharmaceuticals (BDRX), Oncolytics Biotech (ONCY), bluebird bio (BLUE), Aadi Bioscience (AADI), Immix Biopharma (IMMX), and PepGen (PEPG). These companies are all part of the "pharmaceutical products" industry. HCW Biologics vs. Actinium Pharmaceuticals Tenaya Therapeutics Forte Biosciences Skye Bioscience Biodexa Pharmaceuticals Oncolytics Biotech bluebird bio Aadi Bioscience Immix Biopharma PepGen Actinium Pharmaceuticals (NYSE:ATNM) and HCW Biologics (NASDAQ:HCWB) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their community ranking, valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability. Does the MarketBeat Community prefer ATNM or HCWB? Actinium Pharmaceuticals received 3 more outperform votes than HCW Biologics when rated by MarketBeat users. However, 100.00% of users gave HCW Biologics an outperform vote while only 50.00% of users gave Actinium Pharmaceuticals an outperform vote. CompanyUnderperformOutperformActinium PharmaceuticalsOutperform Votes950.00% Underperform Votes950.00% HCW BiologicsOutperform Votes6100.00% Underperform VotesNo Votes Which has preferable valuation and earnings, ATNM or HCWB? HCW Biologics has higher revenue and earnings than Actinium Pharmaceuticals. Actinium Pharmaceuticals is trading at a lower price-to-earnings ratio than HCW Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioActinium Pharmaceuticals$81K496.83-$48.82M-$1.39-0.93HCW Biologics$3.50M2.89-$24.99M-$0.78-0.29 Is ATNM or HCWB more profitable? Actinium Pharmaceuticals has a net margin of 0.00% compared to HCW Biologics' net margin of -1,067.82%. Actinium Pharmaceuticals' return on equity of -100.85% beat HCW Biologics' return on equity.Company Net Margins Return on Equity Return on Assets Actinium PharmaceuticalsN/A -100.85% -47.89% HCW Biologics -1,067.82%-2,516.84%-132.95% Do institutionals and insiders hold more shares of ATNM or HCWB? 27.5% of Actinium Pharmaceuticals shares are owned by institutional investors. Comparatively, 3.0% of HCW Biologics shares are owned by institutional investors. 6.0% of Actinium Pharmaceuticals shares are owned by insiders. Comparatively, 49.9% of HCW Biologics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, ATNM or HCWB? Actinium Pharmaceuticals has a beta of -0.27, suggesting that its share price is 127% less volatile than the S&P 500. Comparatively, HCW Biologics has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500. Does the media prefer ATNM or HCWB? In the previous week, Actinium Pharmaceuticals had 31 more articles in the media than HCW Biologics. MarketBeat recorded 38 mentions for Actinium Pharmaceuticals and 7 mentions for HCW Biologics. Actinium Pharmaceuticals' average media sentiment score of 0.18 beat HCW Biologics' score of -0.19 indicating that Actinium Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Actinium Pharmaceuticals 2 Very Positive mention(s) 2 Positive mention(s) 18 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral HCW Biologics 0 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer ATNM or HCWB? Actinium Pharmaceuticals currently has a consensus target price of $7.40, suggesting a potential upside of 473.64%. Given Actinium Pharmaceuticals' stronger consensus rating and higher probable upside, research analysts clearly believe Actinium Pharmaceuticals is more favorable than HCW Biologics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Actinium Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80HCW Biologics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryActinium Pharmaceuticals beats HCW Biologics on 11 of the 18 factors compared between the two stocks. Remove Ads Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCWB vs. The Competition Export to ExcelMetricHCW BiologicsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.12M$6.32B$5.24B$7.07BDividend YieldN/A2.85%4.87%4.05%P/E Ratio-0.236.7221.1817.48Price / Sales2.89186.91356.3585.27Price / CashN/A65.6738.1634.64Price / Book0.615.576.233.79Net Income-$24.99M$141.67M$3.20B$247.10M7 Day Performance-24.27%-11.44%-8.32%-7.32%1 Month Performance-36.31%-14.59%-3.36%-10.19%1 Year Performance-85.62%-18.30%2.72%-7.41% HCW Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCWBHCW Biologics1.0997 of 5 stars$0.23-4.8%N/A-85.5%$10.12M$3.50M-0.2340Earnings ReportUpcoming EarningsStock SplitNews CoverageGap UpATNMActinium Pharmaceuticals1.9657 of 5 stars$1.61-11.0%$7.40+359.6%N/A$50.23M$81,000.00-1.1630Analyst ForecastAnalyst RevisionNews CoverageGap DownTNYATenaya Therapeutics3.7926 of 5 stars$0.57-11.3%$6.25+996.3%-89.1%$49.93MN/A-0.40110Analyst RevisionGap DownFBRXForte Biosciences2.7008 of 5 stars$7.76-5.4%$23.58+203.9%+22,159.8%$49.61MN/A-0.485Analyst ForecastOptions VolumeNews CoverageGap DownSKYESkye Bioscience1.132 of 5 stars$1.59-15.0%$18.00+1,032.1%-89.5%$49.25MN/A-2.2111Gap DownHigh Trading VolumeBDRXBiodexa Pharmaceuticals0.1404 of 5 stars$1.32+7.3%N/AN/A$48.24M$83,000.000.0020Gap UpONCYOncolytics Biotech1.2077 of 5 stars$0.55-8.3%$4.00+627.3%-53.5%$47.53MN/A-2.0430BLUEbluebird bio2.8031 of 5 stars$4.88+19.6%$44.60+813.9%-79.3%$47.44M$53.12M-0.13520High Trading VolumeAADIAadi Bioscience0.9009 of 5 stars$1.91+0.5%$1.67-12.7%-22.4%$47.17M$25.07M-0.8440Positive NewsIMMXImmix Biopharma1.8824 of 5 stars$1.68-1.2%$7.00+316.7%-48.4%$46.57MN/A-1.989PEPGPepGen1.9991 of 5 stars$1.41-5.1%$10.33+635.5%-88.5%$45.93MN/A-0.4730Gap Down Remove Ads Related Companies and Tools Related Companies Actinium Pharmaceuticals Competitors Tenaya Therapeutics Competitors Forte Biosciences Competitors Skye Bioscience Competitors Biodexa Pharmaceuticals Competitors Oncolytics Biotech Competitors bluebird bio Competitors Aadi Bioscience Competitors Immix Biopharma Competitors PepGen Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCWB) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HCWB Stock Free HCWB Stock Alerts